Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Recap: Iovance Biotherapeutics Q4 Earnings

Iovance Biotherapeutics (NASDAQ:IOVA) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
byBenzinga Insights
February 24, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Iovance Biotherapeutics (NASDAQ:IOVA) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM.

Here’s what investors need to know about the announcement.

Earnings

Iovance Biotherapeutics missed estimated earnings by 12.5%, reporting an EPS of $-0.63 versus an estimate of $-0.56.

Revenue was down $0.00 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.02 which was followed by a 2.0% increase in the share price the next day.

 

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Preview: Evergy’s Earnings

By Benzinga Insights
Today, 11:12 AM
Evergy (NYSE:EVRG) is set to give its latest quarterly earnings report on Friday, 2022-02-25. Here's what investors need to know before the announcement. Analysts estimate that Evergy will report an earnings per share (EPS) of $0.16.

EVRG

Read More

Earnings Outlook For Axcelis Technologies

By Benzinga Insights
Today, 11:12 AM
Axcelis Technologies (NASDAQ:ACLS) is set to give its latest quarterly earnings report on Monday, 2022-02-07. Here's what investors need to know before the announcement. Analysts estimate that Axcelis Technologies will likely report an Earnings Per Share (EPS) of $0.84.

ACLS